Tissue Transglutaminase (tTG; expressed in Baculovirus/Sf9)

Added to your cart

Tissue Transglutaminase (tTG; expressed in Baculovirus/Sf9)

Cart subtotal: £0.00

View cart (0) Checkout

#SKU 15201

Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Tissue transglutaminase (tTG; syn. TGase-2) is an ubiquitously expressed enzyme, which exerts protein deamidation and transamidation activity leading to the creation of neo-epitopes and the cross-linking of proteins, respectively. DIARECT’s tTG has been sequence modified to eliminate this cross-linking activity and to prevent covalent aggregates of tTG with host cell proteins.

1.0 mg

More information



  • Shipping Information
  • Dry ice
  • Abbreviations
  • tTG; BV
  • Recommended Use
  • RUO
  • Storage
  • -70°C or below
  • Shelf Life
  • 5 years from DOM
  • Disease Area
  • Celiac disease
  • Source
  • Baculovirus/Insect cells

Technical Documents

Product Specification (24.01KB)

Certificates Of Analysis (443.6KB)

Safety Data Sheet (55.95KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox